Assurance Medical Inc.
This article was originally published in Start Up
Executive SummaryAssurance Medical has created easy-to-use handheld electronic palpitation devices to help physicians and patients perform breast examinations with much higher sensitivity and consistency.
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Bangladesh’s Beximco will market Mylan’s biosimilars in its domestic market, under a deal that has just been struck between the two companies. The Ogivri trastuzumab biosimilar, co-developed by Mylan and Biocon, will be the first product launched as part of the collaboration.